Invention Application
- Patent Title: 5-HT3 RECEPTOR ANTAGONISTS
-
Application No.: US15599239Application Date: 2017-05-18
-
Publication No.: US20170260201A1Publication Date: 2017-09-14
- Inventor: Stephen Hitchcock , Holger Monenschein , Holly Reichard , Huikai Sun , Shota Kikuchi , Todd Macklin , Maria Hopkins
- Applicant: Takeda Pharmaceutical Company Limited
- Main IPC: C07D498/08
- IPC: C07D498/08 ; C07C53/40 ; C07C53/18 ; A61K31/5386 ; A61K31/19 ; C07D221/22 ; C07D519/00 ; C07D471/04 ; C07D451/12 ; C07D453/02 ; C07D471/08
Abstract:
The present invention provides 5-HT3 receptor antagonists of Formula (I): which are useful for the treatment of diseases treatable by inhibition of 5-HT3 receptor such as emesis, pain, drug addiction, neurodegenerative and psychiatric disorders, and GI disorders. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.
Public/Granted literature
- US10125145B2 5-HT3 receptor antagonists Public/Granted day:2018-11-13
Information query
